KPRX
KPRX
NASDAQ · Pharmaceuticals

Kiora Pharmaceuticals Inc

$2.04
-0.02 (-0.97%)
As of Mar 25, 10:12 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,338.2% upside
Low Target $16.75
Average Target $29.34
High Target $32.13
Current Price $2.04
Current
$2.04
Target
$29.34
$16.75 $29.34 avg $32.13
Scenario Analysis
Bear Case
$16.75
721.1%
Low target
Base Case
$29.34
+1,338.2%
Avg target
Bull Case
$32.13
+1,475.0%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$4.18
-51.2% from high
52-Week Low
$1.76
+15.6% from low
Target vs 52W High
$29.34
+601.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%